Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Targa Resources
TRGP
$64.1B
| $74.3M | 0.04% |
1,509,843
+813,826
| +117% | +$35.8M |
|
427
Synopsys
SNPS
$76.2B
| $74M | 0.04% |
247,206
-101,056
| -29% | -$30.7M |
|
|
WBT
428
DELISTED
Welbilt, Inc.
WBT
| $74M | 0.04% |
3,183,805
+1,213,698
| +62% | +$28.5M |
|
429
Merck
MRK
$376B
| $73.9M | 0.04% |
984,276
+514,993
| +110% | +$39.2M |
|
430
Olin
OLN
$2.1B
| $73.8M | 0.04% |
1,528,577
+937,229
| +158% | +$43.7M |
|
431
Qualcomm
QCOM
$169B
| $73.7M | 0.04% |
571,100
-439,881
| -44% | -$62.4M |
|
432
PUT
Abbott
ABT
$202B
| $73.7M | 0.04% |
623,500
+469,300
| +304% | +$57.6M |
|
433
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $73.6M | 0.04% |
2,305,800
+1,249,800
| +118% | +$41.8M |
|
434
PUT
Royal Caribbean
RCL
$78.1B
| $72.6M | 0.04% |
816,400
+157,500
| +24% | +$12.7M |
|
435
Estee Lauder
EL
$36.9B
| $72.6M | 0.04% |
242,051
+233,423
| +2,705% | +$76.3M |
|
436
Caterpillar
CAT
$381B
| $72.3M | 0.04% |
376,697
-127,301
| -25% | -$26.5M |
|
437
PUT
TC Energy
TRP
$64.6B
| $72.2M | 0.04% |
+1,280,000
| New | +$62.1M |
|
438
S&P Global
SPGI
$127B
| $72.2M | 0.04% |
169,979
+153,366
| +923% | +$66.5M |
|
439
Eastman Chemical
EMN
$8.47B
| $72.2M | 0.04% |
716,774
+679,815
| +1,839% | +$75M |
|
440
Dow Inc
DOW
$23.4B
| $72.1M | 0.04% |
1,252,949
+989,663
| +376% | +$60.6M |
|
|
NSA
441
DELISTED
National Storage Affiliates Trust
NSA
| $72.1M | 0.04% |
1,365,665
-458,978
| -25% | -$25.3M |
|
442
ConocoPhillips
COP
$162B
| $72M | 0.04% |
1,062,569
+66,028
| +7% | +$3.81M |
|
443
PUT
Amgen
AMGN
$238B
| $72M | 0.04% |
338,500
-153,500
| -31% | -$35.3M |
|
444
Brown & Brown
BRO
$24.4B
| $71.8M | 0.04% |
1,294,660
+444,285
| +52% | +$24.8M |
|
|
ZEN
445
DELISTED
ZENDESK INC
ZEN
| $71.6M | 0.04% |
615,170
+201,456
| +49% | +$26M |
|
|
FTCH
446
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $71.6M | 0.04% |
1,910,171
-634,820
| -25% | -$28.1M |
|
447
Baker Hughes
BKR
$61.9B
| $71.5M | 0.04% |
2,892,378
-422,887
| -13% | -$9.42M |
|
448
SolarEdge
SEDG
$1.9B
| $71.5M | 0.04% |
269,495
-130,424
| -33% | -$35.5M |
|
449
Enphase Energy
ENPH
$5.1B
| $71.3M | 0.04% |
475,664
+388,672
| +447% | +$66.7M |
|
450
Celanese
CE
$5.14B
| $71.2M | 0.04% |
472,961
+299,585
| +173% | +$46.1M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.